Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Recent studies add new data to breast cancer research
June 9th, 2005
Investigators in Italy and the South Africa have published new breast cancer data. Study 1: Researchers in Italy report that continuous infusion with combined vinorelbine, epirubicin, and 5-fluorouracil is "an active and manageable first-line regimen for metastatic breast cancer patients." "We investigated the activity and toxicity of a combination of vinorelbine 25 mg/m2 on days 1 and 15; epirubicin 25 mg/m2 on days 1, 8, 15; and 5-fluorouracil continuous infusion at 200 mg/m2 every day, administered as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. Fifty-three patients entered the...
Source: Women's Health Weekly (2005-06-09)
|
